The drugmaker will raise prices on 10% of its drug portfolio.
Group of Takeda investors try to block Shire deal; FDA’s Gottlieb threatens to pull e-cigarettes completely; AstraZeneca’s immunotherapy fails late-stage lung cancer trial.
FDA imposes restrictions on e-cigarette sales; Pfizer launches biosimilar to treat anemia; J&J cleared of liability in one talc case.
Healthcare leaders expect to spend an average of $32 million implementing artificial intelligence into their business.
Juul suspends flavored vape sales in retail stores, quits social media; Google health unit to absorb DeepMind AI health division; Indegene launches digital agency.
A new study suggests creative departments are struggling to keep up data-driven advertising.
The shops were being probed after independent production companies accused advertising agencies of improper practices.
There has been more intrigue and discussion about the point-of-care environment over the past 18 months than in the last decade combined — and the news keeps on coming.
People are more inclined to change their lives for the better when content is motivational instead of based on shock-value, study finds.
Amarin CEO defends Vascepa trial results; Tech companies meet to discuss opioid epidemic; GSK to launch clinical program for pancreatic cancer.